| Literature DB >> 32284060 |
Yunfeng Zhang1,2,3, Qixing Liang1, Chuanzhi Zhang4, Juan Zhang1, Guocheng Du1,2, Zhen Kang5,6.
Abstract
BACKGROUND: Trypsin has many applications in food and pharmaceutical manufacturing. Although commercial trypsin is usually extracted from porcine pancreas, this source carries the risks of infectivity and immunogenicity. Microbial Streptomyces griseus trypsin (SGT) is a prime alternative because it possesses efficient hydrolysis activity without such risks. However, the remarkable hydrolysis efficiency of SGT causes autolysis, and five autolysis sites, R21, R32, K122, R153, and R201, were identified from its autolysate.Entities:
Keywords: Autolysis; Insulin; Pichia pastoris; Streptomyces griseus trypsin; Unfolded protein response (UPR)
Mesh:
Substances:
Year: 2020 PMID: 32284060 PMCID: PMC7155311 DOI: 10.1186/s12934-020-01338-9
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
The production of Streptomyces trypsin in different strains
| Strains | Production | Strategies | References |
|---|---|---|---|
| 6.6 U mL−1 | pWHM3- | [ | |
| 7.4 U mL−1 | Recombinant expression | [ | |
| 12.84 U mL−1 | Co-expressing positive regulatory genes | [ | |
| 15.18 U mL−1 | Expression vectors containing | [ | |
| – | – | [ | |
| 33.8 U mL−1 | [ | ||
| 14.4 U mL−1 | Mature SGT sequence; propeptide swap; fed-batch fermentation | [ | |
| 1.45 U mL−1 | Propeptide engineering; 6.71-fold increased (flask culture) | [ | |
| 47.4 U mL−1 | Auto-catalyzed N-terminal peptide; fed-batch fermentation | [ | |
| 40.5 U mL−1 | Pro-peptide mutation; artificial pro-peptide; single mutation of autolysis residues (flask culture) | [ | |
| 227.65 U mL−1 | Fed-batch fermentation | [ | |
| GS115-tbcf (K101A, R201V) | 60.85 U mL−1 | tbcf (K101A, R201V) mutant, 1.5-fold increased (flask culture) | In study |
| GS115-tbcf (K101A, R201V)-UBC1 | 80.1 U mL−1 | Overexpression UBC1, 1.98-fold increased (flask culture) | In study |
| GS115-tbcf (K101A, R201V)-SSO2 | 86.12 U mL−1 | Overexpression SSO2, 2.13-fold increased (flask culture) | In study |
| GS115-tbcf (K101A, R201V)-SU | 109.25 U mL−1 | Overexpression SSO2 and UBC1, 2.7-fold increased (flask culture) | In study |
| GS115-tbcf (K101A, R201V)-SU | 689.47 U mL−1 | Fed-batch fermentation, threefold increased from GS115-tbcf (101A) | In study |
–, Inclusion body
* The parent strain in this study
Fig. 1Identification of the autolysis residues and predicted mutations. a The peptide fragments detected from the hydrolysate of tbcf (K101A). The peptide fragments are presented in colored sequences. b The predicted mutations of autolysis residues in tbcf (K101A)
Fig. 2Amidase activity of the trypsin variants. Trypsin amidase activity (rectangle), DCW (filled square). a Variant of R201 mutation, b variant of R32 mutation, c variant of R21 mutation, d variant of K122 mutation, e variant of R153 mutation, and f the specific activity of the trypsin mutant
Fig. 3Comparison of the three-dimensional structures of the trypsin mutants tbcf (a) and tbcf (K101A, R201V) (b)
Fig. 4Trypsin amidase activity of the Pichia pastoris yeast strain with overexpression of the endogenous proteins
Fig. 5Fed-batch fermentation of the yeast strain in a 3-L bioreactor. Trypsin amidase activity (triangle), dry cell weight (DCW, square), dissolved oxygen (DO, circle), and rotation speed
Fig. 6HPLC chromatograms of insulin manufactured with trypsin. a Schematic presentation of the hydrolysis process. rPI, recombination insulin precursor; PI-BD30, insulin precursor with Asp30-deleted B-chain. b–d Chromatograms of the hydrolysis products of rPI after incubation with trypsin at 25 °C for 19 h: b rPI, c rPI and commercial porcine trypsin, and d rPI and tbcf (K101A, R201V)